Home > Search: satraplatin

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

All Topic Areas 1 - 10 of 43  more >> Sideroblastic Anemia Saudi Arabia Streptokinase Streptase Streptococcus pneumonia Infection Streptozocin Zanosar Streptomycin Streptococcal Diseases Stevia News 1 - 5 of 14  more >> Spectrum Pharmaceuticals Announces Satraplatin Data Presentation At The American Society Of Clinical Oncology Prostate Cancer Symposium MedicalNewsToday - Sat, 24 Feb 2007 08:00 EST Spectrum Pharmaceuticals Announces Completion Of NDA Filing For Satraplatin For Hormone Refractory Prostate Cancer MedicalNewsToday - Sat, 17 Feb 2007 08:00 EST GPC Biotech Submits NDA For Lead Oncology Drug Candidate Satraplatin MedicalNewsToday - Sat, 17 Feb 2007 08:00 EST Pharmion Corporation And GPC Biotech Announce Positive Results From The Satraplatin Pivotal Phase 3 MedicalNewsToday - Mon, 25 Sep 2006 07:00 EST Spectrum Pharmaceuticals Announces Initiation Of Phase 2 Trial Evaluating Satraplatin In Combination With Tarceva In Patients With Lung Cancer MedicalNewsToday - Sat, 05 Aug 2006 06:00 EST Clinical Trials 1 - 5 of 12  more >> Phase I Study of Satraplatin (JM-216) in Combination with Docetaxel ClinicalTrials.gov Identifier: NCT00125411 - Recruiting Advanced Solid Tumors Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated with One Cytotoxic Chemotherapy Regimen ClinicalTrials.gov Identifier: NCT00069745 - Active, not recruiting Prostate Cancer; Hormone Refractory Prostate Cancer; One Prior Cytotoxic Chemotherapy Regimen Satraplatin for Locally Advanced Non-Small Cell Lung Cancer with Simultaneous Radiotherapy ClinicalTrials.gov Identifier: NCT00093132 - Recruiting Carcinoma, Non-Small Cell Lung; Lung Cancer Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) ClinicalTrials.gov Identifier: NCT00450970 - Active, not recruiting Prostate Cancer A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel ClinicalTrials.gov Identifier: NCT00313456 - Recruiting Tumors; Prostate Cancer

GoldBambooTM Your Integrative Health and Wellness Resource November 30, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.